November 12, 2012 15:08
FAS green-lights AFK Sistema bid to buy 100% of VeroPharm, but with terms (Part 2)
MOSCOW. Nov 12 (Interfax) - Russia's Federal Antimonopoly Service (FAS) has approved AFK Sistema's (RTS: AFKS) request for permission to buy 100% of the stock in pharmaceuticals company OJSC VeroPharm (RTS: VRPH), but has attached some terms, a FAS statement says.
The FAS established that VeroPharm has a dominating position on the market for medicines with MNN Gemifloksatsin, and its subsidiary LLC LENS-Pharm with MNN Poliadenilovaya Kislota + Poliuridilovaya Kislota.
The FAS takes the view that the conduct of this deal could lead to a limiting of access to the market for the sale of these medical preparations by independent counteragent VeroPharm and LENS-Pharm. In light of this, the FAS requires of Sistema and VeroPharm to ensure the fulfillment of all contracts for the delivery of all medicines existing on the date the deal is completed.
Before the deal is done, Sistema is to post on its official website the document regulating its commercial policy as regards VeroPharm medical preparations, and announce changes to commercial policy in letter form to the FAS within thirty days.
The parties are not to, from the date the deal is completed, effect any unfounded economic or technological reduction or halt of the production and supply of goods that are still in demand. They are also to announce to the FAS either of such circumstances in letter form within thirty days.
AFK Sistema and VeroPharm are to annually inform the FAS in letter form that they are meeting these conditions.
The parties to the deal are to announce its completion to the anti-monopoly agency within twenty days from the day the deal is wrapped up.
According to DSM Group data, VeroPharm is third in a rating of the largest Russian pharmaceutical companies. Company product is provided by three plants: in Belgorod, Voronezh, and Pokrov. VeroPharm specializes in the production of Rx medical goods, which account for about 70% of its sales revenues.
Pharmacy Chain 36.6 (RTS: APTK) owns 51.8% of the company.
(Our editorial staff can be reached at email@example.com)
February 27, 2015
Moscow expects sanctions against Iran to be lifted to arrange military-technological cooperation - diplomat
Only 20%-30% of EU enterprises to return to Russian market after embargo canceled - regulator
No rivalry between Summa, RZD China transit projects - ministry
Kyrgyzstan again calls on Belarus to extradite Zhanysh Bakiyev
Odds of reaching Iraq deal exceed likelihood of disruption; delay will be no tragedy - Ryabkov
Cost of construction of energy bridge to Japan may be $5.5 bln-$6 bln - Sakhalin governor
Rally demanding Bakiyevs' extradition held near Belarusian embassy in Bishkek
Russian Church urges world to stop terror, protect Christians in Middle East
Ukraine to start pumping gas into underground storage Feb 27
Belarusian Foreign Ministry says it doubts Bakiyevs could get fair trial in Kyrgyzstan
POSSIBLE DEVELOPMENT OF RUSSIAN-IRANIAN MILITARY AND TECHNICAL COOPERATION WILL NOT DISRUPT BALANCE IN MIDDLE EAST - DEPUTY FM RYABKOV
MOSCOW AWAITS REPELLING UN SANCTIONS ON IRAN TO FINE-TUNE COOPERATION WITH IT IN MILITARY AND TECHNICAL AND NUCLEAR SPHERES - DEPUTY FM RYABKOV
RUSSIA IS STILL INTERESTED IN FRUITFUL COMPLETION OF IRANIAN NUCLEAR ISSUE TALKS - DEPUTY FM RYABKOV